Skip to content

Mass‐information: mephedrone, myths, and the new generation of legal highs

Zoe Davey, Ornella Corazza, Fabrizio Schifano, Paolo Deluca

Drugs and Alcohol Today August 30, 2010 DOI: 10.5042/daat.2010.0467 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Keywords Mephedrone Misinformation Popularity Internet privacy Recreational drug The internet European commission Harm reduction Risk analysis engineering Computer security Pharmacology European union Law World wide web
Citations 30
Key findings The internet has been a key factor in the rapid expansion of the market in licit recreational drugs, particularly mephedrone and related cathinones, and the spread of misinformation about them poses challenges for harm reduction.

Abstract

The market in licit recreational drugs is continuing to grow, both in the UK and elsewhere, and the internet has been acknowledged as a key factor in enabling this rapid expansion over the last few years. This is particularly true of the recent rise in popularity of the substance mephedrone (4-methylmethcathinone) and related cathinones. Keeping up to date with these new drugs and emerging trends is a challenge for both professionals and users, particularly given the relative paucity of balanced and reliable information available and the potential for misinformation to be widely disseminated. This article examines the transmission of inaccurate information in relation to mephedrone and substituted cathinones, and discusses the implication of this for harm reduction and future research, by looking at the results of the European Commission funded Psychonaut Web Mapping project, which used online resources to detect emerging trends, monitor their diffusion, and develop a reasonably accurate profile of these new psychoactive compounds.

Citations in the library